Cargando…

Auraptene ameliorates osteoporosis by inhibiting RANKL/NFATc1 pathway-mediated bone resorption based on network pharmacology and experimental evaluation

AIMS: The association of auraptene (AUR), a 7-geranyloxycoumarin, on osteoporosis and its potential pathway was predicted by network pharmacology and confirmed in experimental osteoporotic mice. METHODS: The network of AUR was constructed and a potential pathway predicted by Kyoto Encyclopedia of Ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Mi H., Choi, La Y., Chung, Jae Y., Kim, Eun-Jung, Yang, Woong M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Editorial Society of Bone & Joint Surgery 2022
Materias:	Bone Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130672/ https://www.ncbi.nlm.nih.gov/pubmed/35579298 http://dx.doi.org/10.1302/2046-3758.115.BJR-2021-0380.R1

Ejemplares similares

Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity
por: He, Jianbo, et al.
Publicado: (2021)

Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression
por: Kim, Eun-Jung, et al.
Publicado: (2018)

Effect of GNAQ alteration on RANKL-induced osteoclastogenesis in human non-small-cell lung cancer
por: Choi, Ji-Yoon, et al.
Publicado: (2020)

Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1
por: Song, Min-Kyoung, et al.
Publicado: (2015)

The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing
por: Starlinger, Julia, et al.
Publicado: (2019)

Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities
por: Liu, Yuhao, et al.
Publicado: (2019)

Rosiglitazone suppresses RANKL‐induced NFATc1 autoamplification by disrupting the physical interaction between NFATc1 and PPARγ
por: Park, Kyeong‐Lok, et al.
Publicado: (2018)

The Coumarin Derivative 5′-Hydroxy Auraptene Suppresses Osteoclast Differentiation via Inhibiting MAPK and c-Fos/NFATc1 Pathways
por: Abdallah, Basem M., et al.
Publicado: (2019)

The Antioxidant Auraptene Improves Aged Oocyte Quality and Embryo Development in Mice
por: Kim, Yun-Hee, et al.
Publicado: (2022)

A novel RANKL‐targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species
por: Hong, Guoju, et al.
Publicado: (2021)

OR13-05 Longitudinal Changes In Bone Turnover Following Withdrawal Of RANKL Inhibition
por: Kim, Albert S, et al.
Publicado: (2023)

Icaritin ameliorates RANKL-mediated osteoclastogenesis and ovariectomy-induced osteoporosis
por: Huang, Jun-ming, et al.
Publicado: (2023)

C-phycocyanin attenuates RANKL-induced osteoclastogenesis and bone resorption in vitro through inhibiting ROS levels, NFATc1 and NF-κB activation
por: AlQranei, Mohammed S., et al.
Publicado: (2020)

SUN-374 Decisions to Accept or Decline Pharmacologic Osteoporosis Therapy After Attending a Novel Patient-Centred Educonsult Program for Osteoporosis (PEP-OP)
por: Liu, Crystal Sixian, et al.
Publicado: (2020)

Follicle-Stimulating Hormone Does Not Impact RANKL-Induced Osteoclastogenesis
por: Zhou, Ziyue, et al.
Publicado: (2021)

Gut microbiome and osteoporosis: a review
por: Li, Sucheng, et al.
Publicado: (2020)

The Phosphoinositide 3-Kinase Isoform PI3Kβ Regulates Osteoclast-Mediated Bone Resorption in Humans and Mice
por: Győri, Dávid, et al.
Publicado: (2014)

Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption
por: Lim, Soomin, et al.
Publicado: (2023)

Interleukin-19 promotes bone resorption by suppressing osteoprotegerin expression in BMSCs in a lipopolysaccharide-induced bone loss mouse model
por: Dai, Zhicheng, et al.
Publicado: (2023)

Evaluation of common variants in the CNR2 gene and its interaction with abdominal obesity for osteoporosis susceptibility in Chinese post-menopausal females
por: Zheng, W., et al.
Publicado: (2019)

Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1
por: Hou, Huanhuan, et al.
Publicado: (2020)

TNFα Increases RANKL Expression via PGE(2)-Induced Activation of NFATc1
por: Park, Hyun-Jung, et al.
Publicado: (2017)

Ectopic parathyroid adenoma with severe osteoporosis in premenopausal woman
por: Ahmadova, Konul
Publicado: (2023)

A Review of Auraptene as an Anticancer Agent
por: Tayarani-Najaran, Zahra, et al.
Publicado: (2021)

Vav1 inhibits RANKL-induced osteoclast differentiation and bone resorption
por: Jang, Jin Sun, et al.
Publicado: (2019)

Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis
por: Kim, Minsun, et al.
Publicado: (2020)

The Dibenzyl Isoquinoline Alkaloid Berbamine Ameliorates Osteoporosis by Inhibiting Bone Resorption
por: Zhang, Chongjing, et al.
Publicado: (2022)

NADPH oxidase gp91(phox) contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1
por: Kang, In Soon, et al.
Publicado: (2016)

Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis Via Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways
por: Hong, Guoju, et al.
Publicado: (2020)

THU428 Association Of Bone Turnover Markers Monitoring With Osteoporosis Medication Adherence In Korea: A Nationwide Cohort Study
por: Ahn, Seong Hee, et al.
Publicado: (2023)

The influence of age and osteoporosis on bone marrow stem cells from rats
por: Sanghani-Kerai, A., et al.
Publicado: (2018)

Development and validation of a gene signature predicting the risk of postmenopausal osteoporosis
por: Yuan, Wei, et al.
Publicado: (2022)

Auraptene in the Peels of Citrus kawachiensis (Kawachi Bankan) Ameliorates Lipopolysaccharide-Induced Inflammation in the Mouse Brain
por: Okuyama, Satoshi, et al.
Publicado: (2014)

Role of RANKL inhibition in osteoporosis
por: McClung, Michael
Publicado: (2007)

Dracorhodin perchlorate inhibits osteoclastogenesis through repressing RANKL‐stimulated NFATc1 activity
por: Liu, Yuhao, et al.
Publicado: (2020)

Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells
por: Kim, Jeong-Mi, et al.
Publicado: (2017)

IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-κB/NFATc1 signaling
por: Kim, Inyoung, et al.
Publicado: (2021)

OR03-2 Different Effects of Abaloparatide and h-PTH(1-34) on Osteoclastogenesis and Bone Resorption
por: Arlt, Heike, et al.
Publicado: (2019)

Is RANKL inhibition both anti-resorptive and anabolic in rheumatoid arthritis?
por: Sims, Natalie A., et al.
Publicado: (2015)

Oat Seedlings Extract Inhibits RANKL-Induced c-Fos/NFATc1 Transcription Factors in the Early Stage of Osteoclast Differentiation
por: Yang, Ji Yeong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ngep7vdjcv6augotianl3m5876